Russell Cassella

Russell Cassella is a Managing Partner at Revelstoke Capital Partners, a Denver-based private equity firm that invests exclusively in the healthcare and related business-services sectors. He joined Revelstoke in 2017 and sits on the firm's Investment Team, where he is responsible for deal sourcing, execution, and portfolio-company monitoring. He is also a member of the firm's Investment Committee and Executive Committee, where his responsibilities include fundraising strategy and execution, oversight of Investor Relations and Responsible Investment, and ongoing deal monitoring.

Before joining Revelstoke, Cassella was a Partner at GCM Grosvenor, where he focused on healthcare and business-services investments and served on 15 boards of directors. Earlier in his career he was a Principal in the Customized Fund Investment Group at Credit Suisse Group AG, and he previously held investment banking, operating, and consulting roles at Deutsche Bank, Diageo, and Deloitte Consulting, respectively.

Cassella earned a B.S. from Carnegie Mellon University and an M.B.A. from New York University's Stern School of Business. At Revelstoke he has taken board roles with portfolio companies including ClareMedica and HealthAxis.

Revelstoke Capital Partners was founded in 2013 by Simon Bachleda (previously a Managing Director at Eos Partners). The firm has grown to several billion dollars in assets under management and, since inception, has completed well over 180 acquisitions comprising roughly two-to-three dozen platform companies and 150-plus add-on acquisitions — with the large majority of its portfolio concentrated in healthcare subsectors.

• Invests as a control private equity buyer, not an angel/seed investor — the "Angel Investors / Seed Round" label in the source stub does not reflect Revelstoke's actual strategy.
• Concentrates on healthcare services, healthcare technology, and health & wellness, including specialty physician practices, rehabilitation services, infusion therapy, and health IT platforms.
• Pursues a platform-plus-add-on ("buy-and-build") model — acquiring a core platform company and then compounding growth through numerous bolt-on acquisitions.
• Targets established, industry-leading businesses the firm can scale operationally, rather than early-stage or pre-revenue startups.
• Cassella personally emphasizes deal sourcing, execution, portfolio monitoring, and LP fundraising/investor relations, reflecting a role focused on both new investments and value creation within the existing portfolio.